Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) varies greatly in different countries or regions, ranging from 13% to 45%. The treatment regimens for PVTT recommended by HCC guidelines in different countries or regions also vary greatly. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhu-Jian, Li, Le, Teng, Yu-Xian, Zhang, Yu-Qi, Zhang, Yu-Xin, Liu, Hao-Tian, Huang, Jian-Li, Liu, Zhen-Xiu, Ma, Liang, Zhong, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845160/
https://www.ncbi.nlm.nih.gov/pubmed/35233384
http://dx.doi.org/10.14218/JCTH.2021.00179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845160/
https://www.ncbi.nlm.nih.gov/pubmed/35233384
http://dx.doi.org/10.14218/JCTH.2021.00179

Ejemplares similares